Drug Type Oligonucleotide |
Synonyms- |
Target |
Action agonists |
Mechanism GDF15 agonists(Growth/differentiation factor 15 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 01 Jul 2025 | |
| Digestive System Disorders | Discovery | - | 01 Jul 2025 | |
| Eczema | Discovery | - | 01 Jul 2025 | |
| Endocrinology and Metabolic Disease | Discovery | - | 01 Jul 2025 | |
| Inflammation | Discovery | - | 01 Jul 2025 | |
| Kidney Diseases | Discovery | - | 01 Jul 2025 |





